BAYLOR MEDICAL CENTER AT FRISCO — History
CCN 450853 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$161M
Latest Revenue (FY2022)
+10.9%
Revenue CAGR (3yr)
10.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $131M | $146M | $161M | +10.6% | +10.9% |
| Operating Expenses | $116M | $120M | $144M | +19.3% | +11.4% |
| Operating Margin | 11.6% | 17.3% | 10.8% | -37.5% | -3.3% |
| Net Income | $15M | $25M | $17M | -30.9% | +7.2% |
| Licensed Beds | 68 | 68 | 68 | +0.0% | +0.0% |
| Total Patient Days | 12,351 | 11,505 | 12,615 | +9.6% | +1.1% |
| Medicare Day % | 8% | 5% | 5% | -11.4% | -22.7% |
| Medicaid Day % | 0% | 0% | 0% | -29.8% | -9.7% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +23.0% ($131M → $161M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.9%
This Hospital
+7.6%
State Avg
Latest Margin
10.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $176M | 10.4% |
| FY2024 (proj) | $191M | 10.0% |
| FY2025 (proj) | $206M | 9.7% |